Enzyme Replacement Therapy
Treatment that supplies a lab-made version of a missing or defective enzyme, usually by infusion, to compensate for a genetic deficiency.
As defined in Biotech’s Chief Evangelist
Where it comes up · 1
- Biotech’s Chief Evangelist3 claims
Most important claims · 3 of 3Search all claims for “Enzyme Replacement Therapy” →
- Pompe disease is caused by lacking or misproducing an enzyme that breaks down glycogen, so glycogen accumulates in muscles and destroys them, and the therapeutic challenge was to build a lab-made enzyme replacement that targets muscle through sugar-based recognition.Biotech’s Chief Evangelist
- The first Pompe enzyme therapy reduced the enlarged left heart of the children by about 3x within 12 weeks, saving their lives, but muscle strength plateaued after about a year and the therapy was not a cure, requiring a next-generation effort.Biotech’s Chief Evangelist
- Making an enzyme replacement therapy for Pompe is deceptively hard because the enzyme must be safe, effective, and reach muscle, with targeting dependent on sugar carbohydrate decorations on the enzyme, a lock-and-key problem.Biotech’s Chief Evangelist